Cost-effectiveness of Daclatasvir in Combination with Sofosbuvir for the Treatment of Subjects with Genotype 3 Chronic Hepatitis C Infection in the United States

被引：0
作者：
Thibault, Catherine St-Laurent [1 ]
Moorjaney, Divya [1 ]
Ganz, Michael [1 ]
Sill, Bruce E. [2 ]
Hede, Shalini [2 ]
Yuan, Yong [2 ]
Kalsekar, Anupama [2 ]
Gorsh, Boris [2 ]
机构：
[1] Evidera, Modeling & Simulat, St Laurent, PQ, Canada
[2] Bristol Myers Squibb Co, Plainsboro, NJ USA
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1461
引用
收藏
页码：923A / 923A
页数：1
相关论文
共 50 条
[31]   Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results [J].
Gandjour, Afschin .
PLOS ONE, 2020, 15 (10)
[32]   COST-EFFECTIVENESS OF TREATING CHRONIC HEPATITIS C GENOTYPE-1 WITH LEDIPASVIR AND SOFOSBUVIR IN GERMANY [J].
Stahmeyer, J. T. ;
Rossol, S. ;
Bert, F. ;
Guerra, I. M. ;
Krauth, C. .
JOURNAL OF HEPATOLOGY, 2015, 62 :S642-S643
[33]   COST-EFFECTIVENESS ANALYSIS OF DACLATASVIR WITH ASUNAPREVIR IN TREATMENT OF CHRONIC HEPATITIS C IN THE RUSSIAN FEDERATION [J].
Yagudina, R. ;
Kulikov, A. ;
Babiy, V. V. .
VALUE IN HEALTH, 2016, 19 (07) :A415-A415
[34]   Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C virus genotype 1 infection in China [J].
Li, Fan ;
Chen, Guofeng ;
Shao, Qing ;
Ji, Dong ;
Li, Bing ;
Li, Zhongbin ;
Liu, Jialiang ;
Liu, Chunxiao ;
Wang, Tingting ;
Wang, Qiaomin ;
Chen, Jing ;
Wu, Vanessa ;
Wong, April ;
Wang, Cheng ;
Wang, Yudong ;
Lau, George K. .
HEPATOLOGY, 2015, 62 :959A-960A
[35]   Cost-effectiveness of treatment for chronic hepatitis C infection - Reply [J].
Salomon, JA ;
Goldie, SJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (15) :1994-1994
[36]   Re: Saint-Laurent Thibault C, Moorjaney D, Ganz ML, et al. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States. J Med Econ 2017;20:692-702 [J].
Patel, Jayeshkumar ;
Zhao, Xiaohui ;
Shah, Drishti ;
Alhussain, Khalid ;
Kamal, Khalid .
JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (11) :1121-1122
[37]   Sofosbuvir-Based Treatment Regimens for Chronic, Genotype 1 Hepatitis C Virus Infection in US Incarcerated Populations A Cost-Effectiveness Analysis [J].
Liu, Shan ;
Watcha, Daena ;
Holodniy, Mark ;
Goldhaber-Fiebert, Jeremy D. .
ANNALS OF INTERNAL MEDICINE, 2014, 161 (08) :546-U43
[38]   Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China [J].
Zhou, Hui Jun ;
Cao, Jing ;
Shi, Hui ;
Naidoo, Nasheen ;
Semba, Sherehe ;
Wang, Pei ;
Fan, Yi Fan ;
Zhu, Shui Cheng .
FRONTIERS IN PUBLIC HEALTH, 2021, 9
[39]   Cost-effectiveness analysis of sofosbuvir plus ledipasivir in the treatment of chronic hepatitis C virus genotype 1 infection in real life practice in China [J].
Li, Bing ;
Chen, Jing ;
Wang, Cheng ;
Wu, Vanessa ;
Wong, April ;
Shao, Qing ;
Ji, Dong ;
Li, Fan ;
Wang, Yudong ;
Niu, Xiaoxia ;
Liu, Jialiang ;
Yang, Wucai ;
Fu, Yiming ;
Chen, Guofeng ;
Lau, George K. .
HEPATOLOGY, 2015, 62 :959A-959A
[40]   COST-EFFECTIVENESS OF SOFOSBUVIR AND LEDIPASVIR IN THE TREATMENT OF PATIENTS WITH HEPATITIS C [J].
Leleu, H. ;
Blachier, M. ;
Hauvespre, A. ;
Pentel, J. .
VALUE IN HEALTH, 2015, 18 (07) :A585-A585
12345